If you have taken Actos, ActoPlus Met, ActoPlus Met XR or Duetact for type II diabetes and have been diagnosed as having bladder cancer, you should talk with a personal injury attorney. These brand-name medicines are also known as pioglitazone. If you have type II diabetes, it is very possible that you are one of the millions of patients who have been prescribed one of these medications. Actos has been on the market since 1999.
Actos bladder cancer complications can include kidney damage, incontinence, urinary blockage and anemia. Additionally, bladder cancer side effects can cause discomfort, pain and a diminished quality of life. If you have suffered due to Actos side effects, you may be entitled to compensation for current and future medical expenses, lost wages if your illness caused you to miss work, pain and suffering, and other injuries.
- May 2012 – Research published in British Medical Journal reveals a nearly doubled risk for bladder cancer caused by Actos, with risks increasing as dosage increases or usage continues. Taking the medicine for two years can double the risk of bladder cancer.
- April 2012 – Health Canada requires label updates due to increased risk of bladder cancers.
- August 2011 – The FDA requires a label update for Actos to show the increased risk of bladder cancer.
- June 2011 – Actos Actos banned in France and Germany. The European Medicines Agency begins a review of the link to bladder cancer.
- June 2011 – Actos linked to 40 percent increase in risk of bladder cancer when used for more than one year. FDA warned that using Actos for more than one year may be associated with an increased risk of bladder cancer. FDA recommended that people receiving treatment for bladder cancer should not take Actos, and Actos should be used with caution in people with a history of bladder cancer. This warning also applies to other diabetes pills containing pioglitazone—Actoplus Met, Actoplus Met XR, and Duetact. Read the safety announcement from the U.S. Food and Drug Administration.
- September 2010 — FDA began reviewing data from a 1o-year study to evaluate the risk of bladder cancer associated with taking Actos.
- 2007 – Competitor drug Avandia was removed from European markets and limited in the U.S.
New Health Problem: Diabetic Macular Edema
Additionally, a June 2012 study published in the Archives of Internal Medicine found that patients who took Actos or other thiazolidinedione drugs had a two- to three-fold increased risk of developing diabetic macular edema. This serious eye condition can lead to blindness. Macular edema is a swelling of the part of the eye that is responsible for sharp, clear vision with looking straight ahead. Edema, or swelling, happens when fluid leads into the center of the macular and blurs vision.
Researchers collected data on 103,368 patients with type 2 diabetes from the British Health Improvement Network database. After one year, 1.3 percent of people taking thiazolidinedione/Actos developed cacular edema , compared to only 0.2 percent of patients who did not take the drugs.
Get Legal Help Now
If you have taken Actos and been diagnosed with bladder cancer, email Carr & Carr Attorneys or call 1-877-392-4878 now to speak with a lawyer who can help you determine what legal action you need to take. There is no cost to you for our initial phone call and you are under no obligation. As personal injury attorneys, we work on a contingency fee basis, meaning you pay for our services only if we settle or win your case.
Depending on the degree of injury and various other factors, you may be entitled to compensation for current medical bills, future medical bills, and pain and suffering. A lawsuit can also help persuade drug makers to make medicine that is safe.
Our personal injury attorneys can help you no matter where in the U.S. you live. We work with families across the nation. With offices located in Tulsa and Oklahoma City, as well as Springdale in Northwest Arkansas, the attorneys at Carr & Carr can help you protect your rights.
Related posts:
- Recall: Avastin Pulled From The Market For Breast Cancer Treatment
- Study: “Jawbone Death” Linked to Fosamax
- Heparin Linked to Numerous Deadly Side Effects
- GranuFlo Possibly Linked To Heart Attacks In Dialysis Patients
- Meningitis Outbreak Linked To Contaminated Steroid
Tags: Actos, bladder cancer, FDA, medicine
